Aadi Bioscience approves retention bonuses for CEO ($390K) and CFO ($220K) through Mar 2025 or change of control

Whitehawk Therapeutics, Inc.

CEO David J. Lennon eligible for $390,000 retention bonus if employed through Mar 31, 2025 or Change of Control.
CFO Scott Giacobello eligible for $220,000 retention bonus under same conditions.
If terminated without cause or resign for good reason before retention date, severance payment equal to bonus (subject to release).
Retention bonus program approved by Compensation Committee on Sept 15, 2024; letters executed Sept 18, 2024.
No change in at-will employment status; bonus is not part of base compensation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.